Cargando…

An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines

INTRODUCTION: It is widely but erroneously believed that drugs get into cells by passing through the phospholipid bilayer portion of the plasma and other membranes. Much evidence shows, however, that this is not the case, and that drugs cross biomembranes by hitchhiking on transporters for other nat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright Muelas, Marina, Roberts, Ivayla, Mughal, Farah, O’Hagan, Steve, Day, Philip J., Kell, Douglas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541387/
https://www.ncbi.nlm.nih.gov/pubmed/33026554
http://dx.doi.org/10.1007/s11306-020-01725-8
_version_ 1783591396626661376
author Wright Muelas, Marina
Roberts, Ivayla
Mughal, Farah
O’Hagan, Steve
Day, Philip J.
Kell, Douglas B.
author_facet Wright Muelas, Marina
Roberts, Ivayla
Mughal, Farah
O’Hagan, Steve
Day, Philip J.
Kell, Douglas B.
author_sort Wright Muelas, Marina
collection PubMed
description INTRODUCTION: It is widely but erroneously believed that drugs get into cells by passing through the phospholipid bilayer portion of the plasma and other membranes. Much evidence shows, however, that this is not the case, and that drugs cross biomembranes by hitchhiking on transporters for other natural molecules to which these drugs are structurally similar. Untargeted metabolomics can provide a method for determining the differential uptake of such metabolites. OBJECTIVES: Blood serum contains many thousands of molecules and provides a convenient source of biologically relevant metabolites. Our objective was to detect and identify metabolites present in serum, but to also establish a method capable of measure their uptake and secretion by different cell lines. METHODS: We develop an untargeted LC-MS/MS method to detect a broad range of compounds present in human serum. We apply this to the analysis of the time course of the uptake and secretion of metabolites in serum by several human cell lines, by analysing changes in the serum that represents the extracellular phase (the ‘exometabolome’ or metabolic footprint). RESULTS: Our method measures some 4000–5000 metabolic features in both positive and negative electrospray ionisation modes. We show that the metabolic footprints of different cell lines differ greatly from each other. CONCLUSION: Our new, 15-min untargeted metabolome method allows for the robust and convenient measurement of differences in the uptake of serum compounds by cell lines following incubation in serum. This will enable future research to study these differences in multiple cell lines that will relate this to transporter expression, thereby advancing our knowledge of transporter substrates, both natural and xenobiotic compounds. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11306-020-01725-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7541387
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-75413872020-10-19 An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines Wright Muelas, Marina Roberts, Ivayla Mughal, Farah O’Hagan, Steve Day, Philip J. Kell, Douglas B. Metabolomics Original Article INTRODUCTION: It is widely but erroneously believed that drugs get into cells by passing through the phospholipid bilayer portion of the plasma and other membranes. Much evidence shows, however, that this is not the case, and that drugs cross biomembranes by hitchhiking on transporters for other natural molecules to which these drugs are structurally similar. Untargeted metabolomics can provide a method for determining the differential uptake of such metabolites. OBJECTIVES: Blood serum contains many thousands of molecules and provides a convenient source of biologically relevant metabolites. Our objective was to detect and identify metabolites present in serum, but to also establish a method capable of measure their uptake and secretion by different cell lines. METHODS: We develop an untargeted LC-MS/MS method to detect a broad range of compounds present in human serum. We apply this to the analysis of the time course of the uptake and secretion of metabolites in serum by several human cell lines, by analysing changes in the serum that represents the extracellular phase (the ‘exometabolome’ or metabolic footprint). RESULTS: Our method measures some 4000–5000 metabolic features in both positive and negative electrospray ionisation modes. We show that the metabolic footprints of different cell lines differ greatly from each other. CONCLUSION: Our new, 15-min untargeted metabolome method allows for the robust and convenient measurement of differences in the uptake of serum compounds by cell lines following incubation in serum. This will enable future research to study these differences in multiple cell lines that will relate this to transporter expression, thereby advancing our knowledge of transporter substrates, both natural and xenobiotic compounds. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11306-020-01725-8) contains supplementary material, which is available to authorized users. Springer US 2020-10-07 2020 /pmc/articles/PMC7541387/ /pubmed/33026554 http://dx.doi.org/10.1007/s11306-020-01725-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Wright Muelas, Marina
Roberts, Ivayla
Mughal, Farah
O’Hagan, Steve
Day, Philip J.
Kell, Douglas B.
An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
title An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
title_full An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
title_fullStr An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
title_full_unstemmed An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
title_short An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
title_sort untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541387/
https://www.ncbi.nlm.nih.gov/pubmed/33026554
http://dx.doi.org/10.1007/s11306-020-01725-8
work_keys_str_mv AT wrightmuelasmarina anuntargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT robertsivayla anuntargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT mughalfarah anuntargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT ohagansteve anuntargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT dayphilipj anuntargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT kelldouglasb anuntargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT wrightmuelasmarina untargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT robertsivayla untargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT mughalfarah untargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT ohagansteve untargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT dayphilipj untargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines
AT kelldouglasb untargetedmetabolomicsstrategytomeasuredifferencesinmetaboliteuptakeandexcretionbymammaliancelllines